Back To: Home : Featured Technology : Flow Cytometry

CLICK HERE FOR WHAT'S NEW IN:
 

Illumina invests in Desktop Genetics’ technology to support platform’s integration with NGS pipelines
January 2016
SHARING OPTIONS:

Desktop Genetics Ltd.
 
Desktop Genetics announced that it has received investment funding from Illumina Inc. The investment will be used to fund the continued development and commercialization of the DESKGEN platform, with a particular focus on integration with next-generation sequencing (NGS) pipelines.
 
The DESKGEN platform makes CRISPR gene editing more predictable, accessible and efficient, providing scientists with the capabilities they need to scale their genomics research. Users are walked through every step of the CRISPR gene editing process with a suite of lab-validated algorithms derived from leading peer-reviewed research and industry expertise. With DESKGEN, researchers can access the latest advances, algorithms and expertise in CRISPR gene editing as new techniques are invented, enhancing their productivity and reducing the time and cost of gene editing.
 
Desktop Genetics Ltd.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.